Hemex Health develops compact diagnostic devices—a Magneto-optical device for malaria and a Hemechip for hemoglobin disorders—that return results from a pinprick of blood in minutes. The devices use disposable cartridges, can wirelessly transmit results, and are designed to be used by primary care providers rather than specialists. The company emphasizes affordability and accessibility to expand testing in resource-limited settings. Hemex was founded in 2016 by Patti White and Peter Galen and is headquartered in the OTRADI Bioscience Incubator in Portland, Ore. The startup employs eight staff and reports a board and scientific advisors spanning four continents. Current prototypes are in clinical trials and the company plans to finalize product design, manufacturing, and distribution as it scales testing.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2017